1-3 of 3
Michael Fulham
Close
Sort by
Journal Articles

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Judith Trotman, Peter Presgrave, Duncan P. Carradice, Douglas Stuart Lenton, Maher Gandhi, Tara Cochrane, Xavier Badoux, Gloria Nkhoma, Belinda Butcher, Michael Fulham, Anna Johnston
Journal: Blood
Blood (2021) 138 (Supplement 1): 2428.
https://doi.org/10.1182/blood-2021-146343
Published: 2021
Journal Articles

A Critical Role for Intratumoral and Circulating LAG3 in Classical Hodgkin Lymphoma: Analysis from the Rathl Prospective Phase III International Clinical Trial

Emad Uddin Abro, BSc, FRACP, FRCPA, MBBS, Soi C Law, PhD, Colm Keane, MB BCh BAO PhDMBA, Simone Birch, MBBS, Muhammed Bilal Sabdia, BSc(Hons), Joshua W.D. Tobin, MD, Peter Johnson, MD, Judith Trotman, Leanne Berkahn, MD, Michael Fulham, Richard A Anderson, Anne L Saunderson, Jay Gunawardana, PhD, Donna Cross, Annette Hernandez, BS, Sarah-Jane Halliday, Robert Bird, FRACP,FRCP,FRCPA,MBBS,MRCP, W P Law, Devinder Gill, MD MRCP, FRCPath, Maher K Gandhi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1621.
https://doi.org/10.1182/blood-2018-99-112008
Published: 2018
Journal Articles

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Judith Trotman, MBChB, FRACP, FRCPA, Marion Fournier, Thierry Lamy, MD, PhD, Jane A Estell, MBBS, FRCPA, FRACP, Anne Sonet, MD, Andrea Janikova, MD, PhD, Herve Tilly, Didier Decaudin, Jean Gabarre, MD, John F Seymour, MD, FRACP, Etienne Garin, Cecily Forsyth, Michael Fulham, MBBS, FRACP, Thierry Vander Borght, MD, PhD, Ofer Shpilberg, MD, MPH, Gilles Salles
Journal: Blood
Blood (2010) 116 (21): 855.
https://doi.org/10.1182/blood.V116.21.855.855
Published: 2010